Ciprofibrate

AssetAlso called Lipanor, NSC-759617, WIN 35833, Modalim

PPARalpha agonist that modifies plasma lipids.

Stage
Approved
Modality
Small molecule
Target
PPARA
3
Indications
1
Trial
1
Developer

Indications

3

In the full profile

  • Target and mechanism1
  • Owner and partners2
  • Trials1
  • Evidence for its targets1
  • Competitors12
  • Signals1

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets